Historial de carrera de Steven Caffé
Antiguos cargos conocidos de Steven Caffé.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CRISPR THERAPEUTICS AG | Consejero General | 04/04/2018 | 01/12/2023 |
SUCAMPO PHARMACEUTICALS, INC. | Consejero General | 27/10/2014 | 04/04/2018 |
RA PHARMACEUTICALS, INC. | Consejero General | - | - |
Sanofi Corp. | Consejero General | - | - |
Aventis, Inc. | Consejero General | - | - |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Consejero General | - | - |
AMAG PHARMACEUTICALS, INC. | Consejero General | 01/06/2013 | - |
BAXTER INTERNATIONAL INC. | Consejero General | - | - |
Formación de Steven Caffé.
Estadísticas
Internacional
Estados Unidos | 8 |
Francia | 2 |
Suiza | 2 |
Operativa
General Counsel | 8 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 7 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
CRISPR THERAPEUTICS AG | Health Technology |
Empresas privadas | 7 |
---|---|
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Université Pierre et Marie Curie | Consumer Services |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Aventis, Inc. | |
Sanofi Corp. | |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Steven Caffé
- Experiencia